AmHS to negotiate drug-benefit alliance
Scott, L.
Modern Healthcare 25(40): 10
1995
ISSN/ISBN: 0160-7480 PMID: 10151431 Document Number: 439658
Document emailed within 1 workday
Related Documents
Gardner, J. 1999: Pharmacists join drug benefit debate. if Medicare offers prescription drug benefit, pharmacists want to be reimbursed Modern Healthcare 29(49): 6DoBias, M. 2007: Senate GOP tosses drug bill. Law would have let Medicare negotiate costs directly Modern Healthcare 37(17): 12
De Coninck, M.J. 1996: L'alliance civile-militaire contre le HIV et le SIDA - The Civil-Military Alliance to combat HIV and AIDS - La Alianza Civico Militar para Combatir el VIH/SIDA Revue Internationale des Services de Sante des Forces Armees 69(7-9): 211-225
De Coninck, M.J. 1996: L'alliance civile-militaire contre le HIV et le SIDA - The Civil-Military Alliance to combat HIV and AIDS - La Alianza Civico Militar para Combatir el VIH/SIDA Revue Internationale des Services de Sante des Forces Armees 69(7-9): 211-225
Scott, L. 1995: SunHealth, AmHS/Premier to merge Modern Healthcare 25(48): 2-3
Wagner, L. 1989: Drug benefit underfunded--report Modern Healthcare 19(20): 26
Greene, J. 1991: Mercy system joins AmHS purchasing program Modern Healthcare 21(8): 6
Penna, P. 2004: Outcomes research in the Medicare drug benefit Managed Care Interface 17(1): 19-20
Wilensky, G.R. 2006: Implementing the Medicare drug benefit--the first 90 days Healthcare Financial Management: Journal of the Healthcare Financial Management Association 60(6): 42-43
Cundiff, D.K. 2003: Medicare prescription drug benefit realities Medgenmed: Medscape General Medicine 5(4): 28
Bower, P. 2009: Drug prevention of hypertension. All cause absolute benefit? Bmj 338: B2597
Greene, J. 1992: AmHS shareholder signs separate supply contract with Baxter Modern Healthcare 22(43): 17
Toivonen, L.; Heikkilä, J. 1986: Drug therapy of arrhythmia--ECG, a "cosmetic" or benefit to the patient? Duodecim; Laaketieteellinen Aikakauskirja 102(22): 1651-1661
Hoffman, R.M. 2000: The clinical benefit of the histoculture drug response assay Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 321-322
Tieman, J. 2003: Senior citizens score win as drug benefit advances Modern Healthcare 33(24): 8-9
2006: Pegaptanib: new drug. In macular degeneration: too many risks for too little benefit Prescrire International 15(84): 127-129
Cook, A.E. 1999: Strategies for containing drug costs: implications for a Medicare benefit Health Care Financing Review 20(3): 29-37
Toivonen, L.; Heikkilä, J. 1987: Drug treatment of arrhythmias -- cosmetics of the ECG or benefit to the patient Annals of Clinical Research 19(1): 1-4
Bengt, J.ön.; Arvidsson, G.ör.; Levin, L.-A.; Rehnberg, C. 2005: Drug utilization decisions should be based on cost-benefit data Lakartidningen 102(16): 1264-1265; Discussion 1265
Demarez, J.P.; Couzinier, J.P.; Begaud, B. 1985: Drug surveillance. Establishment of a benefit/risk ratio in current practice Therapie 40(5): 333-335